0000849146-21-000078 | 10-K | XBRL Viewer

Print Document View Excel Document

Cover Page - USD ($) $ in Millions	12 Months Ended
Cover Page - USD ($) $ in Millions	Jun. 30, 2021	Aug. 13, 2021	Dec. 31, 2020
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 30, 2021
Current Fiscal Year End Date	--06-30
Document Transition Report	false
Entity File Number	001-35647
Entity Registrant Name	LIFEVANTAGE CORP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0224471
Entity Address, Address Line One	3300 N. Triumph Blvd
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Lehi
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84043
City Area Code	801
Local Phone Number	432-9000
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	LFVN
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 131.9
Entity Common Stock, Shares Outstanding		13,647,499
Documents Incorporated by Reference	Portions of the registrant’s definitive proxy statement to be filed subsequent to the date hereof with the Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant’s fiscal year 2022 annual meeting of stockholders are incorporated by reference into Part III of this report. Such definitive proxy statement will be filed with the Commission not later than 120 days after the end of the registrant’s fiscal year ended June 30, 2021.
Entity Central Index Key	0000849146
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020
Current assets
Cash and cash equivalents	$ 23,174	$ 22,138
Accounts receivable	2,925	2,610
Income tax receivable	1,038	0
Inventory, net	16,145	13,888
Prepaid expenses and other	4,772	5,232
Total current assets	48,054	43,868
Non-current assets
Property and equipment, net	11,123	7,170
Right-of-use assets	13,700	956
Intangible assets, net	719	851
Deferred income tax asset	1,208	2,164
Equity securities	2,205	2,205
Other long-term assets	1,723	1,663
TOTAL ASSETS	78,732	58,877
Current liabilities
Accounts payable	6,744	3,521
Commissions payable	8,138	9,219
Income tax payable	830	784
Lease liabilities	2,151	1,184
Other accrued expenses	7,336	10,311
Total current liabilities	25,199	25,019
Long-term lease liabilities	16,032	0
Other long-term liabilities	694	604
Total liabilities	41,925	25,623
Commitments and contingencies — Note 14
Stockholders’ equity
Preferred stock — par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding	0	0
Common stock — par value $0.0001 per share, 40,000 shares authorized and 13,609 and 14,313 issued and outstanding as of June 30, 2021 and 2020, respectively	1	1
Additional paid-in capital	129,048	126,416
Accumulated deficit	(92,346)	(93,307)
Accumulated other comprehensive income	104	144
Total stockholders’ equity	36,807	33,254
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 78,732	$ 58,877

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2021	Jun. 30, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value (dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	13,609,000	14,313,000
Common stock, shares outstanding (in shares)	13,609,000	14,313,000

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Revenue, net	$ 220,181	$ 232,915	$ 225,958
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of sales	$ 38,187	$ 37,964	$ 37,973
Gross profit	181,994	194,951	187,985
Operating expenses:
Commissions and incentives	103,541	111,571	108,620
Selling, general and administrative	60,838	67,914	69,551
Total operating expenses	164,379	179,485	178,171
Operating income	17,615	15,466	9,814
Other expense:
Interest expense	(17)	(120)	(323)
Other expense, net	(366)	(685)	(261)
Total other expense	(383)	(805)	(584)
Income before income taxes	17,232	14,661	9,230
Income tax expense	(4,338)	(3,112)	(1,801)
Net income	$ 12,894	$ 11,549	$ 7,429
Net income per share:
Basic (dollars per share)	$ 0.92	$ 0.82	$ 0.53
Diluted (dollars per share)	$ 0.90	$ 0.79	$ 0.50
Weighted-average shares outstanding:
Basic (in shares)	14,070	14,105	14,055
Diluted (in shares)	14,268	14,599	14,980
Other comprehensive income, net of tax:
Foreign currency translation adjustment	$ (40)	$ 82	$ 48
Other comprehensive income, net of tax:	(40)	82	48
Comprehensive income	$ 12,854	$ 11,631	$ 7,477

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative effect of adoption of accounting principle	Adjusted balance	Common Stock	Common Stock Adjusted balance	Additional Paid-In Capital	Additional Paid-In Capital Adjusted balance	Accumulated Deficit	Accumulated Deficit Cumulative effect of adoption of accounting principle	Accumulated Deficit Adjusted balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Adjusted balance
Beginning balances (in shares) at Jun. 30, 2018				14,073	14,073
Beginning balances at Jun. 30, 2018	$ 21,947	$ (3)	$ 21,944	$ 1	$ 1	$ 124,663	$ 124,663	$ (102,731)	$ (3)	$ (102,734)	$ 14	$ 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	4,899					4,899
Exercise of options (in shares)				155
Exercise of options	701					701
Common stock issued under equity award plans (in shares)				515
Common stock issued under equity award plans	$ 0
Shares canceled or surrendered as payment of tax withholding and other (in shares)	(200)			(240)
Shares canceled or surrendered as payment of tax withholding and other	$ (3,167)					(3,167)
Repurchase of company stock (in shares)				(389)
Repurchase of company stock	(4,655)							(4,655)
Currency translation adjustment	48										48
Net income	7,429							7,429
Ending balances (in shares) at Jun. 30, 2019				14,114	14,114
Ending balances at Jun. 30, 2019	$ 27,199	$ 508	$ 27,707	$ 1	$ 1	127,096	$ 127,096	(99,960)	$ 508	$ (99,452)	62	$ 62
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update	us-gaap:AccountingStandardsUpdate201602Member
Stock-based compensation	$ 4,837					4,837
Common stock issued under employee stock purchase plan (in shares)				64
Common stock issued under employee stock purchase plan	653					653
Exercise of options (in shares)				25
Exercise of options	76					76
Common stock issued under equity award plans (in shares)				910
Common stock issued under equity award plans	$ 0
Shares canceled or surrendered as payment of tax withholding and other (in shares)	(400)			(413)
Shares canceled or surrendered as payment of tax withholding and other	$ (6,246)					(6,246)
Repurchase of company stock (in shares)	(387)
Repurchase of company stock	$ (5,404)
Currency translation adjustment	82										82
Net income	11,549							11,549
Ending balances (in shares) at Jun. 30, 2020				14,313
Ending balances at Jun. 30, 2020	33,254			$ 1		126,416		(93,307)			144
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,152					2,152
Common stock issued under employee stock purchase plan (in shares)				59
Common stock issued under employee stock purchase plan	517					517
Exercise of options (in shares)				289
Exercise of options	1,379					1,379
Common stock issued under equity award plans (in shares)				230
Common stock issued under equity award plans	$ 0
Shares canceled or surrendered as payment of tax withholding and other (in shares)	(100)			(86)
Shares canceled or surrendered as payment of tax withholding and other	$ (1,416)					(1,416)
Repurchase of company stock (in shares)	(1,200)			(1,196)
Repurchase of company stock	$ (11,933)							(11,933)
Currency translation adjustment	(40)										(40)
Net income	12,894							12,894
Ending balances (in shares) at Jun. 30, 2021				13,609
Ending balances at Jun. 30, 2021	$ 36,807			$ 1		$ 129,048		$ (92,346)			$ 104
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update	us-gaap:AccountingStandardsUpdate201602Member

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Cash Flows from Operating Activities:
Net income	$ 12,894	$ 11,549	$ 7,429
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,460	2,777	1,895
Stock-based compensation	2,036	4,919	5,525
Amortization of right-of-use assets	2,365	2,323	0
Gain on sale of fixed assets	(7)	0	0
Amortization of deferred financing fees	0	7	6
Amortization of debt discount	0	39	36
Deferred income tax	955	364	563
Changes in operating assets and liabilities:
Accounts receivable	(265)	(539)	14
Income tax receivable	(1,036)	1,237	(785)
Inventory, net	(2,069)	(152)	(64)
Prepaid expenses and other	486	(29)	1,029
Other long-term assets	59	(483)	7
Accounts payable	3,214	(1,648)	1,369
Income tax payable	46	193	552
Other accrued expenses	(3,659)	432	545
Lease liabilities	(1,913)	(2,698)	0
Other long-term liabilities	(293)	35	(332)
Net Cash Provided by Operating Activities	16,273	18,326	17,789
Cash Flows from Investing Activities:
Investments in convertible note receivable	0	0	(2,000)
Purchase of equipment	(3,741)	(2,681)	(2,506)
Proceeds from sale of fixed assets	7	0	0
Net Cash Used in Investing Activities	(3,734)	(2,681)	(4,506)
Cash Flows from Financing Activities:
Repurchase of company stock	(11,933)	(5,405)	(4,655)
Payment on term loan	0	(1,500)	(4,000)
Shares purchased as payment of tax withholding and other	(1,416)	(6,246)	(3,167)
Proceeds from common stock issued under employee stock purchase plan	517	653	0
Exercise of options and warrants	1,379	76	701
Net Cash Used in Financing Activities	(11,453)	(12,422)	(11,121)
Foreign Currency Effect on Cash	(50)	91	10
Increase in Cash and Cash Equivalents	1,036	3,314	2,172
Cash and Cash Equivalents — beginning of period	22,138	18,824	16,652
Cash and Cash Equivalents — end of period	23,174	22,138	18,824
Non Cash Investing and Financing Activities
Increase in property and equipment and lease liabilities from lease incentives	3,543	0	0
Conversion of convertible notes receivable to equity securities	0	2,205	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	17	44	227
Cash paid for income taxes	$ 4,017	$ 1,623	$ 1,286

The Company	12 Months Ended
The Company	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
The Company	The Company LifeVantage Corporation (the "Company") is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products and a financially rewarding direct sales opportunity to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross border e-commerce business model. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, and Daily Wellness dietary supplements, TrueScience® is the Company's line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. The Company was incorporated in Colorado in June 1988 under the name Andraplex Corporation. The Company changed its corporate name to Yaak River Resources, Inc. in January 1992, and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, the Company acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, the Company changed its name to LifeVantage Corporation. In March 2018, following approval by the Company's stockholders at its fiscal 2018 Annual Meeting of Stockholders, the Company changed its state of incorporation from Colorado to Delaware pursuant to a plan of conversion. All outstanding shares of common stock, options and share units of the Colorado corporation were converted into an equivalent share, option or share unit of the Delaware corporation and the par value of the Company's common stock was adjusted to $0.0001. All directors and officers of the Colorado corporation held the same position within the Delaware corporation on the date of reincorporation.

Summary of Significant Accounting Policies

12 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. Certain other prior period balances have also been reclassified to conform to the current period presentation.

Use of Estimates

The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.

Foreign Currency Translation

A portion of the Company’s business operations occurs outside the United States. The local currency of each of the Company’s subsidiaries generally is its functional currency. All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and as a component of comprehensive

income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.

Fair Value of Financial Instruments

The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.

•Level 1—Quoted prices for identical instruments in active markets;

•Level 2—Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

•Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).

Cash and Cash Equivalents

The Company considers only its monetary liquid assets with original maturities of three months or less to be cash and cash equivalents.

Accounts Receivable

The Company’s accounts receivable for the fiscal years ended June 30, 2021 and 2020 consist primarily of credit card receivables. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June 30, 2021 or 2020 is not necessary. No bad debt expense was recorded for the fiscal years ended June 30, 2021, 2020 and 2019.

Inventory

As of June 30, 2021 and 2020, inventory consisted of (in thousands):


	As of June 30,
	2021				2020
Finished goods	$	12,225	75.7	%	$	10,164	73.2	%
Raw materials	3,920		24.3	%	3,724		26.8	%
Total inventory	$	16,145	100.0	%	$	13,888	100.0	%

Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values of $0.5 million and $0.2 million at June 30, 2021 and 2020, respectively, related to obsolete and slow-moving inventory.

Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


			Years
Equipment (includes computer hardware and software)			3 - 5
Furniture and fixtures			5
Vehicles			5

Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.

The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.

Intangible Assets

Intangible assets are stated at cost less accumulated amortization. Definite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset’s carrying value and estimated fair value.

Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Annual impairment tests on intangible assets were completed for the fiscal years ended June 30, 2021 and 2020, resulting in no impairment charges.

Impairment of Long-Lived Assets

Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow. For the fiscal years ended June 30, 2021 and 2020, management has concluded that there are no indications of impairment.

Concentration of Credit Risk

Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents. At June 30, 2021, the Company had $17.2 million in cash accounts at one financial institution and $6.0 million in other financial institutions. As of June 30, 2021 and 2020, and during the years then ended, the Company’s cash balances exceeded federally insured limits.

Commissions and Incentives

Commissions and incentives expenses are the Company’s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company's independent distributors, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent distributors for personal purchases. Commissions paid to independent distributors on personal purchases are considered a sales discount and are reported as a reduction to net revenue.

Shipping and Handling

Shipping and handling costs associated with inbound freight and freight out to customers, including independent distributors, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.

Research and Development Costs

The Company expenses all costs related to research and development activities as incurred. Research and development expenses for the fiscal years ended June 30, 2021, 2020 and 2019 were $0.7 million, $0.9 million and $1.1 million, respectively.

Leases

The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (“ROU”) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.

Operating lease ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company’s lease agreements do not contain any residual value guarantees.

Stock-Based Compensation

The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.

The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.

The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company’s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.

Income Per Share

Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.

For the fiscal years ended June 30, 2021, 2020 and 2019, the effects of approximately 0.1 million, 0.1 million and 0.2 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock, are not included in the computations as their effect was anti-dilutive.

The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):


	Years ended June 30,
	2021		2020		2019
Numerator:
Net income	$	12,894	$	11,549	$	7,429
Denominator:
Basic weighted-average common shares outstanding	14,070		14,105		14,055
Effect of dilutive securities:
Stock awards and options	198		494		925

Diluted weighted-average common shares outstanding	14,268		14,599		14,980
Net income per share, basic	$	0.92	$	0.82	$	0.53
Net income per share, diluted	$	0.90	$	0.79	$	0.50

Segment Information

The Company operates in a single operating segment by selling products directly to customers through an international network of independent distributors that operates in an integrated manner from market to market. Commissions and incentives expenses are the Company’s largest expense comprised of the commissions paid to its independent distributors. The Company manages its business primarily by managing its international network of independent distributors. The Company disaggregates revenue in two geographic regions: the Americas region and the Asia/Pacific & Europe region. See disaggregated revenue in Note 3.

The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):


	June 30,
	2021		2020
United States	$	22,696	$	10,126
Japan	$	3,363	$	1,070

New Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), which requires all lessees to recognize both a right-of-use asset and lease liability on its balance sheet, representing the obligation to make payments and the right to use or control the use of a specified asset for the lease term. The Company adopted Topic 842 on July 1, 2019, using the modified retrospective transition method. The Company elected the practical expedients available under the provisions of the new standard, including: not reassessing whether expired or existing contracts are or contain leases; not reassessing the classification of expired or existing leases; not reassessing the initial direct cost for any existing leases; and using hindsight in determining the lease term. Upon adoption, the Company recognized cumulative operating lease liabilities of $3.9 million and operating right-of-use assets of $3.3 million. Additionally, a one-time beginning balance adjustment of $0.5 million was recognized in the condensed consolidated statement of stockholders’ equity due to an update to the expected term of an operating lease.

Revenue

12 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Revenue

Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.

The Company generates the majority of its revenue through product sales to customers. These products include the Protandim® line of dietary supplements, LifeVantage® Omega+, ProBio, and Daily Wellness dietary supplements, TrueScience® skin, hair, bath & body and targeted relief, Petandim®, Axio® nootropic energy drink mixes, and the PhysIQ™ smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative

standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.

The Company also charges amounts to independent distributors to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.

Deferred Revenue

The Company records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. Deferred revenue is included in accrued expenses in the condensed consolidated balance sheets. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.

Sales Returns and Allowances

Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company’s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of June 30, 2021 and 2020, the Company’s return liability reserve, net was $0.2 million and $0.3 million, respectively.

Geographic Information

The Company reports revenue in two geographic regions: the Americas region and the Asia/Pacific & Europe region. The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):


	Years ended June 30,
	2021		2020		2019
Americas	$	154,655	$	166,336	$	163,236
Asia/Pacific & Europe	65,526		66,579		62,722
Total revenue	$	220,181	$	232,915	$	225,958

Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):


	Years ended June 30,
	2021		2020		2019
United States	$	144,897	$	155,480	$	151,966
Japan	$	41,173	$	42,343	$	40,796

Major Products

The Company's revenue is largely attributed to two product lines, Protandim® and TrueScience®, which each accounted for more than 10% of total revenue for each of the fiscal years ended June 30, 2021, 2020, and 2019. On a combined basis, the Protandim® and TrueScience® product lines represent approximately 78.5%, 77.3% and 74.8% of the Company's total revenue for the fiscal years ended June 30, 2021, 2020 and 2019, respectively. The following table shows revenue by major product line for the fiscal years ended June 30, 2021, 2020 and 2019:


	Years ended June 30,
	2021				2020				2019
Protandim® product line	$	150,272	68.2	%	$	156,335	67.1	%	$	144,100	63.8	%
TrueScience® product line	22,617		10.3	%	23,739		10.2	%	24,853		11.0	%
Other	47,292		21.5	%	52,841		22.7	%	57,005		25.2	%
Total	$	220,181	100.0	%	$	232,915	100.0	%	$	225,958	100.0	%

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

+ Details

Property and Equipment, Net

12 Months Ended

Jun. 30, 2021

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

Property and equipment, net consist of (in thousands):


	June 30,
	2021		2020
Equipment (includes computer hardware and software)	$	16,850	$	15,297
Furniture and fixtures	1,211		1,622
Leasehold improvements	6,037		3,981
Vehicles	51		51
Accumulated depreciation	(13,026)		(13,781)
Total property and equipment, net	$	11,123	$	7,170

Depreciation expense totaled $3.3 million, $2.6 million and $1.8 million for the fiscal years ended June 30, 2021, 2020 and 2019, respectively.

Intangible Assets, Net

12 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets, Net

Intangible assets, net consist of (in thousands):


	June 30,
	2021		2020
Patent costs	$	2,330	$	2,330
Accumulated amortization	(1,856)		(1,724)
Total definite-lived intangible assets, net	474		606

Trademarks and other indefinite-lived intangible assets	245		245
Total intangible assets, net	$	719	$	851

Amortization expense totaled $0.1 million, $0.1 million and $0.1 million for the fiscal years ended June 30, 2021, 2020 and 2019, respectively. As of June 30, 2021, the remaining weighted-average amortization period for definite-lived intangible assets was 3.75 years. Annual estimated amortization expense is expected to approximate $0.1 million for each of the four succeeding fiscal years.

Gig Economy Group Investment	12 Months Ended
Gig Economy Group Investment	Jun. 30, 2021
Investments, All Other Investments [Abstract]
Gig Economy Group Investment	Gig Economy Group Investment Convertible Note Receivable The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0 million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May 31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May 17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December 31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG’s common stock, par value $0.0001 per share, in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $2.2 million in aggregate consideration). Equity Securities under ASC 321 At December 31, 2019, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, Investments - Equity Securities ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. The estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment. Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. The carrying amount of equity securities held by the Company without readily determinable fair values was $2.2 million at June 30, 2021 and 2020. During the fiscal years ended June 30, 2021 and 2020, there were no price changes or impairments recognized.

Other Accrued Expenses

12 Months Ended

Jun. 30, 2021

Payables and Accruals [Abstract]

Other Accrued Expenses

Other accrued expenses consist of (in thousands):


	June 30,
	2021		2020
Accrued incentive compensation	$	1,497	$	4,552
Other taxes payable	1,959		2,041
Accrued other expenses	1,657		1,108
Accrued payable to vendors	847		1,090
Deferred revenue	319		792

Accrued incentives and promotions to distributors	1,057		728
Total other accrued expenses	$	7,336	$	10,311

Long-Term Debt	12 Months Ended
Long-Term Debt	Jun. 30, 2021
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt On March 30, 2016, the Company entered into a loan agreement (the "2016 Loan Agreement") to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the "Security Agreement"). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the "2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the "2016 Revolving Loan," and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the "2016 Credit Facility"). The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June 30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter. On May 4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (“Amendment No. 1”). Amendment No. 1 revised the maturity date from March 30, 2019 to March 31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants. The Company’s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company’s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan, as amended, exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan, as amended, which is prepaid or repaid may not be re-borrowed. On February 1, 2019, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility, as amended ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million. On April 1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March 31, 2021 to March 31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. As of June 30, 2021, the effective interest rate is 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3). There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 2. The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company's ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company's assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain a certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of June 30, 2021, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended. The Company’s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Jun. 30, 2021
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity During the fiscal years ended June 30, 2021, 2020 and 2019, the Company issued 0.3 million, 25,000 and 0.2 million shares, respectively, of common stock as a result of the exercise of options and warrants. During the fiscal years ended June 30, 2021, 2020 and 2019, the Company issued 0.2 million, 0.9 million and 0.5 million shares, respectively, under the Company's equity incentive plans. During the fiscal years ended June 30, 2021, 2020 and 2019, 0.1 million, 0.4 million and 0.2 million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting. During the fiscal years ended June 30, 2021 and 2020, the Company sold 0.1 million and 0.1 million shares under its 2019 Employee Stock Purchase Plan, respectively. No shares were sold under this plan during the fiscal year ended June 30, 2019. On November 27, 2017, the Company's board of directors approved a stock repurchase plan, which was subsequently amended on February 1, 2019. Under the plan, the Company was authorized to repurchase up to $15.0 million of its outstanding shares through November 27, 2020. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 2023.The repurchase program permits the Company to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management, in accordance with applicable securities laws. As part of the repurchase program, the Company may enter into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan would be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. During year ended June 30, 2021, the Company purchased 1.2 million shares of its common stock at an aggregate purchase price of $11.9 million under this repurchase program. During year ended June 30, 2020, the Company purchased 0.4 million shares of its common stock at an aggregate purchase price of $5.4 million under this repurchase program. At June 30, 2021, there is $11.5 million remaining under this repurchase program. The Company’s Certificate of Incorporation authorizes the designation and issuance shares of preferred stock. However, as of June 30, 2021, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company’s board of directors.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Share-Based Compensation

12 Months Ended

Jun. 30, 2021

Share-based Payment Arrangement [Abstract]

Share-Based Compensation

Long-Term Incentive Plans

Equity-Settled Plans

The Company adopted, and the shareholders approved, the 2007 Long-Term Incentive Plan (the “2007 Plan”), effective November 21, 2006, to provide incentives to certain eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company’s common stock can be issued under the 2007 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2007 Plan and are outstanding to various employees, officers, directors, Scientific Advisory Board members and independent distributors at prices between $9.31 and $10.50 per share, with initial vesting periods of one to three years. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2007 Plan upon expiration of the award. The contractual term of stock options granted is generally ten years. No new awards can be granted under the 2007 Plan. As of June 30, 2021, under the 2007 Plan, there were stock option awards outstanding, net of awards expired, for the purchase in aggregate of 9,700 shares of the Company’s common stock.

The Company adopted, and the shareholders approved, the 2010 Long-Term Incentive Plan (the “2010 Plan”), effective September 27, 2010, as amended on August 21, 2014, to provide incentives to certain eligible employees, directors and consultants. A maximum of 1.0 million shares of the Company’s common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices between $9.31 and $20.09 per share, and vest over one to four year vesting periods. Awards expire in accordance with the terms of each award. The contractual term of stock options granted is generally ten years. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of June 30, 2021, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 27,000 shares of the Company’s common stock.

The Company adopted, and the shareholders approved, the 2017 Long-Term Incentive Plan (the “2017 Plan”), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the shareholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares, and 650,000 shares respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of June 30, 2021, a maximum of 2.9 million shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 2,440,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. Outstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2007 Plan and 2010 Plan. As of June 30, 2021, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company’s common stock.

Cash-Settled Plans

Performance Units

The Company adopted a performance incentive plan effective July 1, 2017 (the "Fiscal 2018 Performance Plan"). The Fiscal 2018 Performance Plan is intended to provide selected employees an opportunity to earn performance-based cash bonuses whose value is based upon the Company’s stock value and to encourage such employees to provide services to the Company and to attract new individuals with outstanding qualifications. The Fiscal 2018 Performance Plan seeks to achieve this purpose by providing for awards in the form of performance share units (the “Units”). No shares will be issued under the Fiscal 2018 Performance Plan. Awards may be settled only with cash and will be paid subsequent to award vesting. The fair value of share-based compensation awards, that include performance shares, are accounted for as liabilities. Vesting for the Units is subject to achievement of both service-based and performance-based vesting requirements. Performance-based vesting occurs in three installments if the Company meets certain performance criteria generally set for each year of a three-year performance period. The service-based vesting criteria occurs in a single installment at the end of the third fiscal year after the awards are granted if the participant has continuously remained in service from the date of award through the end of the third

fiscal year. The fair value of these awards is based on the trading price of the Company's common stock and is remeasured at each reporting period date until settlement.

Phantom Units

During the fiscal year ended June 30, 2018, the Company awarded phantom units to its executive officers and senior management. The vesting date for the phantom units was December 31, 2018, at which time the units would be settled in cash equal to (i) the number of vested units multiplied by (ii) the positive difference (if any) between the value at December 31, 2018 and $4.76, the closing price of the Company's common stock on the start date. The start date is December 29, 2017, the last business day of calendar year 2017. The fair value of these awards is based on the Black-Scholes valuation model and is remeasured at each reporting period date until settlement.

Upon vesting of the phantom units, the awards were partially settled in cash and partially settled with the issuance of restricted stock units. The restricted stock units were issued on January 8, 2019 and vest in a single installment after a one-year vesting period, subject to continued service through the vesting date. On January 8, 2020, the restricted stock units were fully vested. As of June 30, 2021 and 2020, there were no restricted stock units outstanding related to the phantom units.

Employee Stock Purchase Plan

General. The Company’s 2019 Employee Stock Purchase Plan ("ESPP") was adopted by its board of directors in September 2018 and its stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.

Share Reserve. The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of June 30, 2021, 0.3 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).

Purchase Price. Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee’s contributions to the ESPP are limited to 15% of the compensation, and up to a maximum of 3,000 shares may be purchased by an employee during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant’s rights to purchase stock to accrue at a rate exceeding $25,000 fair market value of stock for each calendar year in which such option is outstanding at any time.

Offering Periods. Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.

During the fiscal years ended June 30, 2021 and 2020, 0.1 million and 0.1 million shares of common stock were purchased under the ESPP, respectively. During the fiscal year ended June 30, 2019, no shares of common stock were purchased under the ESPP.

Stock-Based Compensation

In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. For the fiscal years ended June 30, 2021, 2020 and 2019, stock-based compensation of $2.2 million, $4.8 million and $4.9 million, respectively, was reflected as an increase to additional paid in capital and a reduction of $0.1 million, and increase of $0.1 million and $0.6 million, respectively, was reflected in other accrued expenses, all of which was employee related.

At June 30, 2021, there was $1.8 million of unrecognized compensation cost related to nonvested share-based compensation arrangements under the 2010 and 2017 Plans, based on management's estimate of the shares that will ultimately vest. The Company expects to recognize such costs over a weighted-average period of 1.94 years.

Stock Options

During the fiscal year ended June 30, 2018, the Company awarded stock options ("FY 2018 Stock Options") to its executive officers and senior management. The vesting period for the FY 2018 Stock Options is three years and occurs as follows, subject to continued service through the applicable vesting dates: one-third of the total number of shares awarded vests on January 1, 2019; and one-twelfth of the total number of shares awarded vests on the last day of each fiscal quarter following January 1, 2019. The fair value of the stock options will be recognized on a straight-line basis over the requisite service period of the awards.

There were no stock option grants during the fiscal years ended June 30, 2021, 2020 and 2019.

The following is a summary of stock option activity for the fiscal years ended June 30, 2021, 2020 and 2019:


	Options (in thousands)	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2018	730	$	4.96

Granted	—	$	—
Exercised	(155)	4.52			$	1,328
Forfeited	(19)	4.58
Expired or Canceled	(29)	4.64
Outstanding at June 30, 2019	527	5.12

Granted	—	$	—
Exercised	(25)	3.00			$	283
Forfeited	(1)	20.09
Expired or Canceled	(5)	4.11
Outstanding at June 30, 2020	496	5.23

Granted	—	$	—
Exercised	(289)	4.77			$	1,590
Forfeited	(20)	4.82
Expired or Canceled	(9)	6.19
Outstanding at June 30, 2021	178	5.96		5.40	$	410
Exercisable at June 30, 2021	178	$	5.96	5.40	$	410

Restricted Stock Awards

The following is a summary of restricted stock award activity during the fiscal years ended June 30, 2021, 2020 and 2019:


	Shares (in thousands)	Weighted Average Grant Date Fair Value
Nonvested at June 30, 2018	109	$	5.43

Granted	37	$	11.59
Vested	(56)	5.55
Forfeited	—	—
Nonvested at June 30, 2019	90	7.87


Granted	30	$	15.2
Vested	(80)	8.19
Forfeited	—	—
Nonvested at June 30, 2020	40	12.74


Granted	41	$	11.14
Vested	(40)	12.74
Forfeited	—	—
Nonvested at June 30, 2021	41	11.14

The total vesting date fair value of restricted shares that vested during the fiscal years ended June 30, 2021, 2020 and 2019 was $0.5 million, $1.0 million and $0.7 million, respectively.

Restricted Stock Units

The following is a summary of restricted stock units activity during the fiscal years ended June 30, 2021, 2020 and 2019:


	Number of Units (in thousands)	Weighted Average Grant Date Fair Value
Nonvested at June 30, 2018	—	$	—

Granted	347	$	13.81
Vested	—	—
Forfeited	(7)	13.51
Nonvested at June 30, 2019	340	13.81


Granted	122	$	13.64
Vested	(221)	13.87
Forfeited	(2)	12.92
Nonvested at June 30, 2020	239	13.68


Granted	202	$	12.77
Vested	(135)	13.07
Forfeited	(121)	14.60
Nonvested at June 30, 2021	185	12.54

The total vesting date fair value of restricted stock units that vested during the fiscal years ended June 30, 2021 and 2020 was $1.6 million and $3.3 million, respectively. No restricted stock units vested during the fiscal year ended June 30, 2019.

Performance Restricted Stock Units

During the fiscal year ended June 30, 2019, the Company awarded performance restricted stock units ("FY 2019 Performance Restricted Stock Units") to certain employees (the "FY 2019 Recipients"). Each FY 2019 Performance Restricted Stock Unit represents a contingent right for the FY 2019 Recipients to receive a distribution of shares of common stock of the Company equal to 0% to 200% of the target number of performance restricted stock units subject to the award. The actual number of shares distributed will be based on the Company's achievement of specified financial performance metrics. The performance period for the FY 2019 Performance Restricted Stock Units ended June 30, 2019. The FY 2019 Performance Restricted Stock Units will vest only to the extent the specified financial performance criteria are achieved and subject to the FY 2019 Recipient’s continued service with the Company, as follows: (i) a portion of the earned award will vest on the first anniversary of the grant date and (ii) an additional portion of the earned award will vest thereafter in a series of quarterly installments. The fair values of the FY 2019 Performance Restricted Stock Units were based on the grant date fair value which is the closing price of the Company's common stock on the date of grant. During the fiscal years ended June 30, 2021 and 2020, the Company awarded performance restricted stock units ("FY 2021 Performance Restricted Stock Units" and "FY 2020 Performance Restricted Stock Units") to certain employees. The FY 2021 Performance Restricted Stock Units and FY 2020 Performance Restricted Stock Units include terms that are substantially the same as described above for the FY 2019 Performance Restricted Stock Units.

The following is a summary of performance restricted stock units activity during the fiscal years ended June 30, 2021, 2020 and 2019:


	Number of Units (in thousands)	Weighted Average Grant Date Fair Value
Nonvested at June 30, 2018	630	$	8.82

Granted	348	$	12.98
Vested	(479)	13.28
Forfeited	(49)	4.99
Nonvested at June 30, 2019	450	7.71

Granted(1)	357	$	6.96
Vested(1)	(658)	5.88
Forfeited	(40)	15.02
Nonvested at June 30, 2020	109	13.61

Granted	49	$	14.50
Vested(1)	(55)	13.08
Forfeited	(91)	14.39
Nonvested at June 30, 2021	12	13.85


(1)			Includes shares added based on achievement of performance goals in excess of target.

The total vesting date fair value of performance restricted stock units that vested during the fiscal years ended June 30, 2021, 2020, and 2019 was $0.6 million, $10.1 million, and $6.3 million, respectively.

Cash-Settled Performance Units

The following is a summary of cash-settled performance units activity during the fiscal years ended June 30, 2020 and 2019:


	Number of Units (in thousands)	Weighted Average Grant Date Fair Value
Outstanding at June 30, 2018, nonvested	58

Granted	42	$	11.27
Vested	(32)	—
Forfeited	(18)	9.07
Outstanding at June 30, 2019, nonvested	50

Granted	—	$	—
Vested	(42)	—
Forfeited	(8)	7.68
Outstanding at June 30, 2020, nonvested	—

The fair value of vested awards under the cash-settled performance plan for the fiscal years ended June 30, 2020 and 2019 was $0.4 million and $0.4 million, respectively. All vested awards under the cash-settle performance plan were cash-settled as of June 30, 2021. Payments of $0.4 million, $0.3 million and $0.3 million were made to settle vested cash-settled performance units during the fiscal years ended June 30, 2021, 2020 and 2019, respectively.

Cash-Settled Phantom Units

The following is a summary of cash-settled phantom units activity during the fiscal year ended June 30, 2019:


	Number of Units (in thousands)	Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2018, nonvested	170		$	273

Granted	—	—	—
Vested	(170)	—	1,619
Forfeited	—	—	—
Outstanding at June 30, 2019, nonvested	—	—	$	—

No phantom units were outstanding as of June 30, 2021, 2020 and 2019.

Other Expense, Net

12 Months Ended

Jun. 30, 2021

Other Income and Expenses [Abstract]

Other Expense, Net

Other expense, net consists of the following (in thousands):


	Year ended June 30,
	2021		2020		2019

Foreign currency transaction gain (loss), net	$	201	$	(434)	$	(121)
Loss on settlement of forward contract	(571)		(368)		(287)
Gain on disposal of fixed assets	7		3		—

Other (expense) income, net	(3)		114		147
Total other expense, net	$	(366)	$	(685)	$	(261)

Income Taxes

12 Months Ended

Jun. 30, 2021

Income Tax Disclosure [Abstract]

Income Taxes

The income tax expense for the fiscal years ended June 30, 2021, 2020 and 2019 consists of the following (in thousands):


	Year ended June 30,
	2021		2020		2019
Income Before Income Taxes:
Domestic	$	15,233	$	12,817	$	6,596
International	1,999		1,844		2,634
	$	17,232	$	14,661	$	9,230
Current Taxes:
Federal	$	2,146	$	1,297	$	222
State	510		332		176
Foreign	730		1,113		833
Total Current Income Tax Provision	$	3,386	$	2,742	$	1,231
Deferred Taxes:
Federal	$	897	$	316	$	502
State	197		71		109
Foreign	(142)		(17)		(41)
Total Deferred Income Tax Provision	$	952	$	370	$	570
Net Income Tax Provision	$	4,338	$	3,112	$	1,801

The effective income tax rate for the fiscal years ended June 30, 2021, 2020 and 2019 differs from the U.S. Federal statutory income tax rate due to the following:


	Year ended June 30,
	2021		2020		2019
Federal statutory income tax rate	21.0	%	21.0	%	21.0	%
State income taxes, net of federal benefit	3.6	%	3.8	%	3.1	%
Foreign tax rate difference	2.1	%	1.4	%	4.5	%
Tax return to provision true-up	(0.7)	%	0.0	%	(1.1)	%
Limit on future stock compensation due to 162(m)	1.7	%	2.3	%	2.6	%
Foreign withholding tax	0.4	%	3.3	%	0.0	%
Other differences	1.5	%	1.9	%	(0.1)	%
Revalue of deferred for change in federal tax rate	0.1	%	(0.1)	%	(0.6)	%
Permanent differences:
— stock based compensation	(2.3)	%	(13.6)	%	(7.7)	%
— current year section 162(m) limitation	0.0	%	1.6	%	0.0	%
— foreign derived intangible income deduction	(0.6)	%	(0.5)	%	(0.1)	%

— tax credits	(1.4)	%	(2.3)	%	(3.7)	%
— meals and entertainment	0.1	%	0.4	%	0.7	%
— other permanent differences	0.9	%	1.8	%	1.7	%
Change in valuation allowance	(1.2)	%	0.2	%	(0.8)	%
Net income tax provision	25.2	%	21.2	%	19.5	%

The components of the deferred tax assets and liabilities as of June 30, 2021 and 2020 are as follows (in thousands):


	June 30,
	2021		2020
Deferred tax assets:
Federal, state, and foreign net operating loss carryovers	$	271	$	501
Stock option compensation	444		824
Accrued vacation, allowance for returns, bonuses & other	2,104		2,067
Gross deferred tax asset	$	2,819	$	3,392

Deferred tax liabilities:
Patents and trademarks	$	(99)	$	(117)

Property & equipment	(1,250)		(801)
Other	(189)		(59)
Gross deferred tax liabilities	(1,538)		(977)
Less: valuation allowance	(73)		(251)
Deferred tax assets, net	$	1,208	$	2,164

The Company has adopted accounting guidance for uncertain tax positions which provides that in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position. The measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon recognition of the benefit. Currently, the Company has no material uncertain tax positions and does not expect significant changes within the next twelve months. Accordingly, the Company has not reserved for any corresponding interest or penalties.

In fiscal 2020, the Company recorded an uncertain tax position related to withholding taxes in Taiwan. During fiscal 2021, the Company applied for and received approval for a reduced withholding rate. The Company has not yet made the withholding payments but has accrued for the liability as of the balance sheet date. The Company will make the required payments in the beginning of fiscal 2022.

The beginning balance, ending balance, and changes to the liability for uncertain tax positions for the fiscal years ending June 30, 2021 and 2020 are as follows (in thousands):


	June 30,
	2021		2020
Unrecognized tax benefits, beginning of period	$	480	$	—
Gross increases - tax positions in prior period	—		—
Gross decreases - tax positions in prior period	(480)		—
Gross increases - tax positions in current period	—		480
Settlement	—		—
Lapse of statute of limitations	—		—
Currency adjustment	—		—
Unrecognized tax benefits, end of period	$	—	$	480

The tax years open for examination by the Internal Revenue Service (“IRS”) include returns for fiscal years June 30, 2018 through present and the open tax years by state tax authorities include returns for fiscal years June 30, 2017 through present. In addition, the IRS and state tax authorities may examine NOLs for any previous years if utilized by the Company.

As of June 30, 2021, the Company had utilized all of its Federal net operating loss (“NOL”) carry-forwards. The net operating losses were to expire by June 30, 2024 and are subject to review by the Internal Revenue Service, and are subject to U.S. Internal Revenue Code Section 382 limitations. As of June 30, 2021, state NOLs were $6.7 million and foreign NOLs were $0.1 million.

The total recognized tax benefit from settlement of stock based awards for the fiscal years ending June 30, 2021 and 2020, was $8,000 and $2.0 million, respectively.

The Company conducts its business globally. As a result, the Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and are subject to examination for the open tax years of June 30, 2017 through June 30, 2021.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Leases

12 Months Ended

Jun. 30, 2021

Leases [Abstract]

Leases

The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of approximately two to eleven years. As of June 30, 2021, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.93 years and 3.28%, respectively.

For the fiscal years ended June 30, 2021 and 2020, operating lease expense was $3.6 million and $2.7 million, respectively.

Supplemental cash flow information related to operating leases was as follows (in thousands):


	June 30, 2021		June 30, 2020
Operating cash outflows from operating leases	$	2,536	$	2,886
Right-of-use assets obtained in exchange for lease obligations	$	15,725	$	—

Maturity of lease liabilities at June 30, 2021 are as follows (in thousands):


Year ended June 30,	Amount
2022	$	2,550
2023	3,167
2024	1,876
2025	1,606
2026	1,646
Thereafter	9,810
Total	20,655
Less: imputed interest	(2,472)
Present value of lease liabilities	$	18,183

Rent expense under ASC 840 totaled $2.7 million for the fiscal year ended June 30, 2019.

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Contingencies The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June 30, 2021, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements. Legal Accruals In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors. Class Action Lawsuit (Smith v. LifeVantage Corp.): On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company’s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties’ briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs’ Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs’ claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court’s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs’ remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties’ agreement on a schedule for discovery and other litigation matters. Initial discovery has begun and will continue per the amended scheduling order. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. The court has not set a hearing for the motion for class certification and it is unknown when the court may rule. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.Other Matters. In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this annual report on Form 10-K, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.

Related Party Transactions	12 Months Ended
Related Party Transactions	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party TransactionsThe Company has entered into a series of agreements with GEG for outsourced software application development services. The Company and GEG have also entered into a common stock purchase agreement. For discussion related to the common stock purchase agreement, see Note 6. Two members of the Company's board of directors serve on the GEG board of directors. During the fiscal year ended June 30, 2020, the Company paid $1.2 million to GEG for software application development services. No payments were made to GEG for software and application development services during the fiscal year ended June 30, 2021.

Interim Financial Results (Unaudited)

12 Months Ended

Jun. 30, 2021

Quarterly Financial Information Disclosure [Abstract]

Interim Financial Results (Unaudited)

The following summarizes selected quarterly financial information for quarterly periods during the fiscal years ended June 30, 2021 and 2020:

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED QUARTERLY RESULTS

(in thousands except per share data)


	Fiscal Quarter								Year ended June 30, 2021
	First		Second		Third		Fourth
Revenue, net	$	54,827	$	59,007	$	51,570	$	54,777	$	220,181
Gross profit	45,429		48,818		42,752		44,995		181,994
Net income	$	2,451	$	3,812	$	1,724	$	4,907	$	12,894
Per common share:
Income per share, basic	$	0.17	$	0.27	$	0.12	$	0.36	$	0.92
Income per share, diluted	$	0.17	$	0.26	$	0.12	$	0.35	$	0.90


	Fiscal Quarter								Year ended June 30, 2020
	First		Second		Third		Fourth
Revenue, net	$	56,228	$	61,242	$	56,077	$	59,368	$	232,915
Gross profit	47,038		51,012		46,982		49,919		194,951
Net income	$	1,761	$	4,303	$	1,661	$	3,824	$	11,549
Per common share:
Income per share, basic	$	0.13	$	0.31	$	0.12	$	0.27	$	0.82
Income per share, diluted	$	0.12	$	0.30	$	0.11	$	0.26	$	0.79

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Consolidation

Use of Estimates

Foreign Currency Translation

income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.

Fair Value of Financial Instruments

•Level 1—Quoted prices for identical instruments in active markets;

•Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Cash and Cash Equivalents

The Company considers only its monetary liquid assets with original maturities of three months or less to be cash and cash equivalents.

Accounts Receivable

Accounts ReceivableThe Company’s accounts receivable for the fiscal years ended June 30, 2021 and 2020 consist primarily of credit card receivables. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June 30, 2021 or 2020 is not necessary.

Inventory

Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method

Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


			Years
Equipment (includes computer hardware and software)			3 - 5
Furniture and fixtures			5
Vehicles			5

Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.

Intangible Assets

Impairment of Long-Lived Assets

Impairment of Long-Lived AssetsPursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow.

Concentration of Credit Risk

Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents.

Commissions and Incentives

Shipping and Handling

Research and Development Costs

Research and Development CostsThe Company expenses all costs related to research and development activities as incurred.

Leases

Stock-Based Compensation

Income Taxes

Income Per Share

Segment Information

Segment InformationThe Company operates in a single operating segment by selling products directly to customers through an international network of independent distributors that operates in an integrated manner from market to market. Commissions and incentives expenses are the Company’s largest expense comprised of the commissions paid to its independent distributors. The Company manages its business primarily by managing its international network of independent distributors. The Company disaggregates revenue in two geographic regions: the Americas region and the Asia/Pacific & Europe region.

New Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Schedule of Components of Inventory

As of June 30, 2021 and 2020, inventory consisted of (in thousands):


	As of June 30,
	2021				2020
Finished goods	$	12,225	75.7	%	$	10,164	73.2	%
Raw materials	3,920		24.3	%	3,724		26.8	%
Total inventory	$	16,145	100.0	%	$	13,888	100.0	%

Schedule of Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


			Years
Equipment (includes computer hardware and software)			3 - 5
Furniture and fixtures			5
Vehicles			5

Property and equipment, net consist of (in thousands):


	June 30,
	2021		2020
Equipment (includes computer hardware and software)	$	16,850	$	15,297
Furniture and fixtures	1,211		1,622
Leasehold improvements	6,037		3,981
Vehicles	51		51
Accumulated depreciation	(13,026)		(13,781)
Total property and equipment, net	$	11,123	$	7,170

Summary of Computation of Net Income Per Share


	Years ended June 30,
	2021		2020		2019
Numerator:
Net income	$	12,894	$	11,549	$	7,429
Denominator:
Basic weighted-average common shares outstanding	14,070		14,105		14,055
Effect of dilutive securities:
Stock awards and options	198		494		925

Diluted weighted-average common shares outstanding	14,268		14,599		14,980
Net income per share, basic	$	0.92	$	0.82	$	0.53
Net income per share, diluted	$	0.90	$	0.79	$	0.50

Schedule of Long-lived Assets by Geographic Areas

The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):


	June 30,
	2021		2020
United States	$	22,696	$	10,126
Japan	$	3,363	$	1,070

Revenue (Tables)

12 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):


	Years ended June 30,
	2021		2020		2019
Americas	$	154,655	$	166,336	$	163,236
Asia/Pacific & Europe	65,526		66,579		62,722
Total revenue	$	220,181	$	232,915	$	225,958

Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):


	Years ended June 30,
	2021		2020		2019
United States	$	144,897	$	155,480	$	151,966
Japan	$	41,173	$	42,343	$	40,796

Schedule of Revenues by Major Product Line

The following table shows revenue by major product line for the fiscal years ended June 30, 2021, 2020 and 2019:


	Years ended June 30,
	2021				2020				2019
Protandim® product line	$	150,272	68.2	%	$	156,335	67.1	%	$	144,100	63.8	%
TrueScience® product line	22,617		10.3	%	23,739		10.2	%	24,853		11.0	%
Other	47,292		21.5	%	52,841		22.7	%	57,005		25.2	%
Total	$	220,181	100.0	%	$	232,915	100.0	%	$	225,958	100.0	%

Property and Equipment, Net (Tables)

12 Months Ended

Jun. 30, 2021

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


			Years
Equipment (includes computer hardware and software)			3 - 5
Furniture and fixtures			5
Vehicles			5

Property and equipment, net consist of (in thousands):


	June 30,
	2021		2020
Equipment (includes computer hardware and software)	$	16,850	$	15,297
Furniture and fixtures	1,211		1,622
Leasehold improvements	6,037		3,981
Vehicles	51		51
Accumulated depreciation	(13,026)		(13,781)
Total property and equipment, net	$	11,123	$	7,170

Intangible Assets, Net (Tables)

12 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Intangible assets, net consist of (in thousands):


	June 30,
	2021		2020
Patent costs	$	2,330	$	2,330
Accumulated amortization	(1,856)		(1,724)
Total definite-lived intangible assets, net	474		606

Trademarks and other indefinite-lived intangible assets	245		245
Total intangible assets, net	$	719	$	851

Other Accrued Expenses (Tables)

12 Months Ended

Jun. 30, 2021

Payables and Accruals [Abstract]

Schedule of Other Accrued Expenses

Other accrued expenses consist of (in thousands):


	June 30,
	2021		2020
Accrued incentive compensation	$	1,497	$	4,552
Other taxes payable	1,959		2,041
Accrued other expenses	1,657		1,108
Accrued payable to vendors	847		1,090
Deferred revenue	319		792

Accrued incentives and promotions to distributors	1,057		728
Total other accrued expenses	$	7,336	$	10,311

Share-Based Compensation (Tables)

12 Months Ended

Jun. 30, 2021

Share-based Payment Arrangement [Abstract]

Summary of Stock Option Activity

The following is a summary of stock option activity for the fiscal years ended June 30, 2021, 2020 and 2019:


	Options (in thousands)	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2018	730	$	4.96

Granted	—	$	—
Exercised	(155)	4.52			$	1,328
Forfeited	(19)	4.58
Expired or Canceled	(29)	4.64
Outstanding at June 30, 2019	527	5.12

Granted	—	$	—
Exercised	(25)	3.00			$	283
Forfeited	(1)	20.09
Expired or Canceled	(5)	4.11
Outstanding at June 30, 2020	496	5.23

Granted	—	$	—
Exercised	(289)	4.77			$	1,590
Forfeited	(20)	4.82
Expired or Canceled	(9)	6.19
Outstanding at June 30, 2021	178	5.96		5.40	$	410
Exercisable at June 30, 2021	178	$	5.96	5.40	$	410

Schedule of Nonvested Restricted Shares

The following is a summary of restricted stock award activity during the fiscal years ended June 30, 2021, 2020 and 2019:


	Shares (in thousands)	Weighted Average Grant Date Fair Value
Nonvested at June 30, 2018	109	$	5.43

Granted	37	$	11.59
Vested	(56)	5.55
Forfeited	—	—
Nonvested at June 30, 2019	90	7.87


Granted	30	$	15.2
Vested	(80)	8.19
Forfeited	—	—
Nonvested at June 30, 2020	40	12.74


Granted	41	$	11.14
Vested	(40)	12.74
Forfeited	—	—
Nonvested at June 30, 2021	41	11.14

Schedule of Unvested Restricted Stock Units Roll Forward

The following is a summary of restricted stock units activity during the fiscal years ended June 30, 2021, 2020 and 2019:


	Number of Units (in thousands)	Weighted Average Grant Date Fair Value
Nonvested at June 30, 2018	—	$	—

Granted	347	$	13.81
Vested	—	—
Forfeited	(7)	13.51
Nonvested at June 30, 2019	340	13.81


Granted	122	$	13.64
Vested	(221)	13.87
Forfeited	(2)	12.92
Nonvested at June 30, 2020	239	13.68


Granted	202	$	12.77
Vested	(135)	13.07
Forfeited	(121)	14.60
Nonvested at June 30, 2021	185	12.54

Summary of Nonvested Restricted Stock Units

The following is a summary of performance restricted stock units activity during the fiscal years ended June 30, 2021, 2020 and 2019:


	Number of Units (in thousands)	Weighted Average Grant Date Fair Value
Nonvested at June 30, 2018	630	$	8.82

Granted	348	$	12.98
Vested	(479)	13.28
Forfeited	(49)	4.99
Nonvested at June 30, 2019	450	7.71

Granted(1)	357	$	6.96
Vested(1)	(658)	5.88
Forfeited	(40)	15.02
Nonvested at June 30, 2020	109	13.61

Granted	49	$	14.50
Vested(1)	(55)	13.08
Forfeited	(91)	14.39
Nonvested at June 30, 2021	12	13.85


(1)			Includes shares added based on achievement of performance goals in excess of target.

Schedule of Performance Share Units Activity

The following is a summary of cash-settled performance units activity during the fiscal years ended June 30, 2020 and 2019:


	Number of Units (in thousands)	Weighted Average Grant Date Fair Value
Outstanding at June 30, 2018, nonvested	58

Granted	42	$	11.27
Vested	(32)	—
Forfeited	(18)	9.07
Outstanding at June 30, 2019, nonvested	50

Granted	—	$	—
Vested	(42)	—
Forfeited	(8)	7.68
Outstanding at June 30, 2020, nonvested	—

Summary of Cash-Settled Phantom Units

The following is a summary of cash-settled phantom units activity during the fiscal year ended June 30, 2019:


	Number of Units (in thousands)	Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2018, nonvested	170		$	273

Granted	—	—	—
Vested	(170)	—	1,619
Forfeited	—	—	—
Outstanding at June 30, 2019, nonvested	—	—	$	—

Other Expense, Net (Tables)

12 Months Ended

Jun. 30, 2021

Other Income and Expenses [Abstract]

Schedule of Other Expense, Net

Other expense, net consists of the following (in thousands):


	Year ended June 30,
	2021		2020		2019

Foreign currency transaction gain (loss), net	$	201	$	(434)	$	(121)
Loss on settlement of forward contract	(571)		(368)		(287)
Gain on disposal of fixed assets	7		3		—

Other (expense) income, net	(3)		114		147
Total other expense, net	$	(366)	$	(685)	$	(261)

Income Taxes (Tables)

12 Months Ended

Jun. 30, 2021

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense

The income tax expense for the fiscal years ended June 30, 2021, 2020 and 2019 consists of the following (in thousands):


	Year ended June 30,
	2021		2020		2019
Income Before Income Taxes:
Domestic	$	15,233	$	12,817	$	6,596
International	1,999		1,844		2,634
	$	17,232	$	14,661	$	9,230
Current Taxes:
Federal	$	2,146	$	1,297	$	222
State	510		332		176
Foreign	730		1,113		833
Total Current Income Tax Provision	$	3,386	$	2,742	$	1,231
Deferred Taxes:
Federal	$	897	$	316	$	502
State	197		71		109
Foreign	(142)		(17)		(41)
Total Deferred Income Tax Provision	$	952	$	370	$	570
Net Income Tax Provision	$	4,338	$	3,112	$	1,801

Schedule of The Effective Income Tax Rate Differs from the U.S. Federal Statutory Income Tax Rate

The effective income tax rate for the fiscal years ended June 30, 2021, 2020 and 2019 differs from the U.S. Federal statutory income tax rate due to the following:


	Year ended June 30,
	2021		2020		2019
Federal statutory income tax rate	21.0	%	21.0	%	21.0	%
State income taxes, net of federal benefit	3.6	%	3.8	%	3.1	%
Foreign tax rate difference	2.1	%	1.4	%	4.5	%
Tax return to provision true-up	(0.7)	%	0.0	%	(1.1)	%
Limit on future stock compensation due to 162(m)	1.7	%	2.3	%	2.6	%
Foreign withholding tax	0.4	%	3.3	%	0.0	%
Other differences	1.5	%	1.9	%	(0.1)	%
Revalue of deferred for change in federal tax rate	0.1	%	(0.1)	%	(0.6)	%
Permanent differences:
— stock based compensation	(2.3)	%	(13.6)	%	(7.7)	%
— current year section 162(m) limitation	0.0	%	1.6	%	0.0	%
— foreign derived intangible income deduction	(0.6)	%	(0.5)	%	(0.1)	%

— tax credits	(1.4)	%	(2.3)	%	(3.7)	%
— meals and entertainment	0.1	%	0.4	%	0.7	%
— other permanent differences	0.9	%	1.8	%	1.7	%
Change in valuation allowance	(1.2)	%	0.2	%	(0.8)	%
Net income tax provision	25.2	%	21.2	%	19.5	%

Schedule of The Components of the Deferred Tax Assets and Liabilities

The components of the deferred tax assets and liabilities as of June 30, 2021 and 2020 are as follows (in thousands):


	June 30,
	2021		2020
Deferred tax assets:
Federal, state, and foreign net operating loss carryovers	$	271	$	501
Stock option compensation	444		824
Accrued vacation, allowance for returns, bonuses & other	2,104		2,067
Gross deferred tax asset	$	2,819	$	3,392

Deferred tax liabilities:
Patents and trademarks	$	(99)	$	(117)

Property & equipment	(1,250)		(801)
Other	(189)		(59)
Gross deferred tax liabilities	(1,538)		(977)
Less: valuation allowance	(73)		(251)
Deferred tax assets, net	$	1,208	$	2,164

Schedule of Unrecognized Tax Benefits Roll Forward

The beginning balance, ending balance, and changes to the liability for uncertain tax positions for the fiscal years ending June 30, 2021 and 2020 are as follows (in thousands):


	June 30,
	2021		2020
Unrecognized tax benefits, beginning of period	$	480	$	—
Gross increases - tax positions in prior period	—		—
Gross decreases - tax positions in prior period	(480)		—
Gross increases - tax positions in current period	—		480
Settlement	—		—
Lapse of statute of limitations	—		—
Currency adjustment	—		—
Unrecognized tax benefits, end of period	$	—	$	480

Leases (Tables)

12 Months Ended

Jun. 30, 2021

Leases [Abstract]

Schedule of Lease, Cost

Supplemental cash flow information related to operating leases was as follows (in thousands):


	June 30, 2021		June 30, 2020
Operating cash outflows from operating leases	$	2,536	$	2,886
Right-of-use assets obtained in exchange for lease obligations	$	15,725	$	—

Schedule of Lessee, Operating Lease, Liability, Maturity

Maturity of lease liabilities at June 30, 2021 are as follows (in thousands):


Year ended June 30,	Amount
2022	$	2,550
2023	3,167
2024	1,876
2025	1,606
2026	1,646
Thereafter	9,810
Total	20,655
Less: imputed interest	(2,472)
Present value of lease liabilities	$	18,183

Interim Financial Results (Unaudited) (Tables)

12 Months Ended

Jun. 30, 2021

Quarterly Financial Information Disclosure [Abstract]

Summary of Selected Quarterly Financial Information

The following summarizes selected quarterly financial information for quarterly periods during the fiscal years ended June 30, 2021 and 2020:

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED QUARTERLY RESULTS

(in thousands except per share data)


	Fiscal Quarter								Year ended June 30, 2021
	First		Second		Third		Fourth
Revenue, net	$	54,827	$	59,007	$	51,570	$	54,777	$	220,181
Gross profit	45,429		48,818		42,752		44,995		181,994
Net income	$	2,451	$	3,812	$	1,724	$	4,907	$	12,894
Per common share:
Income per share, basic	$	0.17	$	0.27	$	0.12	$	0.36	$	0.92
Income per share, diluted	$	0.17	$	0.26	$	0.12	$	0.35	$	0.90


	Fiscal Quarter								Year ended June 30, 2020
	First		Second		Third		Fourth
Revenue, net	$	56,228	$	61,242	$	56,077	$	59,368	$	232,915
Gross profit	47,038		51,012		46,982		49,919		194,951
Net income	$	1,761	$	4,303	$	1,661	$	3,824	$	11,549
Per common share:
Income per share, basic	$	0.13	$	0.31	$	0.12	$	0.27	$	0.82
Income per share, diluted	$	0.12	$	0.30	$	0.11	$	0.26	$	0.79

The Company (Details) - $ / shares	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common stock, par value (dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001

Summary of Significant Accounting Policies - Narrative (Details) shares in Millions	12 Months Ended
	Jun. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2021 USD ($) shares	Jun. 30, 2021 USD ($) lease	Jun. 30, 2021 USD ($) segment	Jun. 30, 2021 USD ($) region	Jun. 30, 2020 USD ($) shares	Jun. 30, 2019 USD ($) shares	Jun. 30, 2018 USD ($)	Jul. 01, 2019 USD ($)
Summary of Significant Accounting Policies Additional Information [Abstract]
Recorded bad debt expense		$ 0					$ 0	$ 0
Inventory valuation reserves	$ 500,000	500,000	$ 500,000	$ 500,000	$ 500,000	$ 500,000	200,000
Impairment of intangible assets		0					0
Research and development		700,000					$ 900,000	$ 1,100,000
Number of finance leases \| lease				0
Number of antidilutive securities (in shares) \| shares			0.1				0.1	0.2
Number of geographic segments					2	2
Accounting standards update	us-gaap:AccountingStandardsUpdate201602Member							us-gaap:AccountingStandardsUpdate201602Member	us-gaap:AccountingStandardsUpdate201602Member
Lease liabilities	$ 18,183,000	18,183,000	$ 18,183,000	$ 18,183,000	$ 18,183,000	$ 18,183,000
Right-of-use assets	13,700,000	13,700,000	13,700,000	13,700,000	13,700,000	13,700,000	$ 956,000
Stockholders' equity attributable to parent	$ 36,807,000	36,807,000	$ 36,807,000	$ 36,807,000	$ 36,807,000	$ 36,807,000	$ 33,254,000	$ 27,199,000	$ 21,947,000
Cumulative effect of adoption of accounting principle
Summary of Significant Accounting Policies Additional Information [Abstract]
Lease liabilities										$ 3,900,000
Right-of-use assets										3,300,000
Stockholders' equity attributable to parent								$ 508,000	$ (3,000)	$ 500,000
Cash Accounts Held Primarily At Financial Institution
Summary of Significant Accounting Policies Additional Information [Abstract]
Concentration of credit risk		17,200,000
Cash Accounts Held at Other Financial Institutions
Summary of Significant Accounting Policies Additional Information [Abstract]
Concentration of credit risk		$ 6,000,000.0

Summary of Significant Accounting Policies - Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020
Components of Inventory
Finished goods	$ 12,225	$ 10,164
Raw materials	3,920	3,724
Total inventory	$ 16,145	$ 13,888
Finished goods	75.70%	73.20%
Raw materials	24.30%	26.80%
Total inventory	100.00%	100.00%

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Jun. 30, 2021
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	5 years
Vehicles
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	5 years
Minimum \| Equipment (includes computer hardware and software)
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	3 years
Maximum \| Equipment (includes computer hardware and software)
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	5 years

Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Numerator:
Net income	$ 4,907	$ 1,724	$ 3,812	$ 2,451	$ 3,824	$ 1,661	$ 4,303	$ 1,761	$ 12,894	$ 11,549	$ 7,429
Denominator:
Basic weighted-average common shares outstanding (in shares)									14,070	14,105	14,055
Effect of dilutive securities:
Stock awards and options (in shares)									198	494	925
Diluted weighted-average common shares outstanding (in shares)									14,268	14,599	14,980
Income per share, basic (dollars per share)	$ 0.36	$ 0.12	$ 0.27	$ 0.17	$ 0.27	$ 0.12	$ 0.31	$ 0.13	$ 0.92	$ 0.82	$ 0.53
Income per share, diluted (dollars per share)	$ 0.35	$ 0.12	$ 0.26	$ 0.17	$ 0.26	$ 0.11	$ 0.30	$ 0.12	$ 0.90	$ 0.79	$ 0.50

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

Summary of Significant Accounting Policies - Segment Information (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 22,696	$ 10,126
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 3,363	$ 1,070

Revenue - Narrative (Details) $ in Millions	12 Months Ended
Revenue - Narrative (Details) $ in Millions	Jun. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2021 USD ($) segment	Jun. 30, 2021 USD ($) region	Jun. 30, 2021 USD ($) productLine	Jun. 30, 2020 USD ($)	Jun. 30, 2019
Revenue from External Customer [Line Items]
Money back guarantee period	30 days
Handling and restocking fee, percentage	10.00%	10.00%	10.00%	10.00%	10.00%
Return liability reserve \| $	$ 0.2	$ 0.2	$ 0.2	$ 0.2	$ 0.2	$ 0.3
Number of geographic segments			2	2
Number of product lines \| productLine					2
Product concentration risk \| Revenue benchmark
Revenue from External Customer [Line Items]
Concentration risk		100.00%				100.00%	100.00%
Product concentration risk \| Revenue benchmark \| Protandim and TrueScience Product Line
Revenue from External Customer [Line Items]
Concentration risk		78.50%				77.30%	74.80%

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of Revenue [Line Items]
Revenue, net	$ 54,777	$ 51,570	$ 59,007	$ 54,827	$ 59,368	$ 56,077	$ 61,242	$ 56,228	$ 220,181	$ 232,915	$ 225,958
Americas
Disaggregation of Revenue [Line Items]
Revenue, net									154,655	166,336	163,236
Asia/Pacific & Europe
Disaggregation of Revenue [Line Items]
Revenue, net									65,526	66,579	62,722
United States
Disaggregation of Revenue [Line Items]
Revenue, net									144,897	155,480	151,966
Japan
Disaggregation of Revenue [Line Items]
Revenue, net									$ 41,173	$ 42,343	$ 40,796

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Revenue - Major Products (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Revenue - Major Products (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Revenue from External Customer [Line Items]
Revenue, net	$ 54,777	$ 51,570	$ 59,007	$ 54,827	$ 59,368	$ 56,077	$ 61,242	$ 56,228	$ 220,181	$ 232,915	$ 225,958
Product concentration risk \| Revenue benchmark
Revenue from External Customer [Line Items]
Concentration risk									100.00%	100.00%	100.00%
Protandim® product line
Revenue from External Customer [Line Items]
Revenue, net									$ 150,272	$ 156,335	$ 144,100
Protandim® product line \| Product concentration risk \| Revenue benchmark
Revenue from External Customer [Line Items]
Concentration risk									68.20%	67.10%	63.80%
TrueScience® product line
Revenue from External Customer [Line Items]
Revenue, net									$ 22,617	$ 23,739	$ 24,853
TrueScience® product line \| Product concentration risk \| Revenue benchmark
Revenue from External Customer [Line Items]
Concentration risk									10.30%	10.20%	11.00%
Other
Revenue from External Customer [Line Items]
Revenue, net									$ 47,292	$ 52,841	$ 57,005
Other \| Product concentration risk \| Revenue benchmark
Revenue from External Customer [Line Items]
Concentration risk									21.50%	22.70%	25.20%

- Definition

+ References

+ Details

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Property, Plant and Equipment [Line Items]
Accumulated depreciation	$ (13,026)	$ (13,781)
Total property and equipment, net	11,123	7,170
Depreciation expense	3,300	2,600	$ 1,800
Equipment (includes computer hardware and software)
Property, Plant and Equipment [Line Items]
Property and equipment, gross	16,850	15,297
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,211	1,622
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,037	3,981
Vehicles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 51	$ 51

Intangible Assets, Net (Details) - USD ($) $ in Thousands	12 Months Ended
Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Indefinite-lived Intangible Assets [Line Items]
Total intangible assets, net	$ 719	$ 851
Amortization of intangible assets	$ 100	100	$ 100
Definite-lived intangible assets weighted-average amortization period	3 years 9 months
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]
2022	$ 100
2023	100
2024	100
2025	100
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Trademarks and other indefinite-lived intangible assets	245	245
Patents
Finite-Lived Intangible Assets [Line Items]
Patent costs	2,330	2,330
Accumulated amortization	(1,856)	(1,724)
Total definite-lived intangible assets, net	$ 474	$ 606

Gig Economy Group Investment (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Dec. 16, 2019	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2018
Related Party Transaction [Line Items]
Common stock, par value (dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Equity securities held without readily determinable value		$ 2.2	$ 2.2
GEG
Related Party Transaction [Line Items]
Notes receivable related party maximum commitment		$ 2.0
Debt conversion, interest rate of debt		8.00%
GEG \| Common Stock
Related Party Transaction [Line Items]
Debt conversion, converted instrument, shares issued (in shares)	1,000,000
Common stock, par value (dollars per share)	$ 0.0001
Debt conversion, converted instrument, amount	$ 2.2

Other Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020
Payables and Accruals [Abstract]
Accrued incentive compensation	$ 1,497	$ 4,552
Other taxes payable	1,959	2,041
Accrued other expenses	1,657	1,108
Accrued payable to vendors	847	1,090
Deferred revenue	319	792
Accrued incentives and promotions to distributors	1,057	728
Total other accrued expenses	$ 7,336	$ 10,311

Long-Term Debt (Details)				12 Months Ended
Long-Term Debt (Details)	Apr. 01, 2021	Feb. 01, 2019 USD ($)	May 04, 2018 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Mar. 30, 2016 USD ($)
Line of Credit Facility [Line Items]
Principal payment				$ 0	$ 1,500,000	$ 4,000,000
Revolving Credit Facility \| Line of Credit
Line of Credit Facility [Line Items]
Total liabilities to tangible net worth ratio (not greater than)				2.00
Floor interest rate	4.00%
Debt instrument, effective interest rate				4.00%
Revolving Credit Facility \| US Treasury (UST) Interest Rate \| Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate	3.00%
March 2016 Term Loan \| Secured Debt
Line of Credit Facility [Line Items]
Maximum borrowing capacity							$ 10,000,000.0
Periodic principal payment				$ 500,000
Fixed interest rate			5.68%				4.93%
Fixed charge coverage ratio, minimum		1.10	1.25				1.50
Trailing period		12 months	12 months
Minimum working capital		$ 6,000,000.0	$ 8,000,000.0				$ 5,000,000.0
Total liabilities to tangible net worth ratio (not greater than)			3.00
March 2016 Revolving Loan \| Secured Debt
Line of Credit Facility [Line Items]
Principal payment		2,000,000.0
March 2016 Revolving Loan \| Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 5,000,000.0					$ 2,000,000.0

Stockholders' Equity (Details) - USD ($)	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019	Aug. 27, 2020	Feb. 01, 2019
Class of Stock [Line Items]
Shares canceled or surrendered as payment of tax withholding and other (in shares)	100,000	400,000	200,000
Repurchase common stock amount authorized (up to)				$ 35,000,000	$ 15,000,000.0
Stock repurchased during period (in shares)	1,200,000	387,000
Payments for repurchase of common stock	$ 11,933,000	$ 5,405,000	$ 4,655,000
Remaining authorized amount of common stock repurchase program	$ 11,500,000
ESPP
Class of Stock [Line Items]
Common stock issued under employee stock purchase plan (in shares)			0
Restricted Stock
Class of Stock [Line Items]
Restricted common stock to employees (in shares)	200,000	900,000	500,000
Common Stock
Class of Stock [Line Items]
Common stock issued (in shares)	289,000	25,000	155,000
Restricted common stock to employees (in shares)	230,000	910,000	515,000
Shares canceled or surrendered as payment of tax withholding and other (in shares)	86,000	413,000	240,000
Common stock issued under employee stock purchase plan (in shares)	59,000	64,000
Stock repurchased during period (in shares)	1,196,000		389,000

Share-Based Compensation - Equity-Settled Plans, Narrative (Details) - $ / shares						12 Months Ended
	Nov. 12, 2020	Nov. 15, 2018	Feb. 02, 2018	Sep. 27, 2010	Nov. 21, 2006	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company's common stock purchased in aggregate (in shares)						178,000	496,000	527,000	730,000
2007 Long-Term Inventive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum common stock issued under Long-Term Incentive Plan (in shares)					1,400,000
Contractual term of stock options granted					10 years
Company's common stock purchased in aggregate (in shares)						9,700
2007 Long-Term Inventive Plan \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to purchase common stock, minimum price (dollars per share)					$ 9.31
Vesting period					1 year
2007 Long-Term Inventive Plan \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to purchase common stock, minimum price (dollars per share)					$ 10.50
Vesting period					3 years
2010 Long-Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum common stock issued under Long-Term Incentive Plan (in shares)			475,000	1,000,000.0
Contractual term of stock options granted				10 years
Company's common stock purchased in aggregate (in shares)						27,000
2010 Long-Term Incentive Plan \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to purchase common stock, minimum price (dollars per share)				$ 9.31
Vesting period				1 year
2010 Long-Term Incentive Plan \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to purchase common stock, minimum price (dollars per share)				$ 20.09
Vesting period				4 years
2017 Long-Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum common stock issued under Long-Term Incentive Plan (in shares)						2,900,000
Vesting period						3 years
Company's common stock purchased in aggregate (in shares)						100,000
Number of additional shares authorized	650,000	715,000	425,000
Exercise price of outstanding stock options (dollars per share)						$ 4.44
2017 Long Term Incentive Plan Excluding 2010 Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum common stock issued under Long-Term Incentive Plan (in shares)			2,440,000

Share-Based Compensation - Cash-Settled Plans, Narrative (Details)		12 Months Ended
	Jan. 08, 2019	Jun. 30, 2021 installment shares	Jun. 30, 2020 shares	Dec. 29, 2017 $ / shares
Cash-Settled Phantom Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (dollars per share) \| $ / shares				$ 4.76
RSUs outstanding \| shares		0	0
2018 Performance Incentive Plan \| Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of vesting installments \| installment		3
Vesting period		3 years
2018 Performance Incentive Plan \| Cash-Settled Phantom Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year

Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details) - ESPP - USD ($)	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock subject for purchase	400,000
Number of shares available for issuance	300,000
Purchase price of stock fair market value	85.00%
Maximum percentage of employee compensation	15.00%
Maximum number of shares that can be purchased during any offering period	3,000
Amount in excess of fair market value of stock for option not to be granted	$ 25,000
Offering period	6 months
Common stock issued under employee stock purchase plan (in shares)	100,000	100,000	0

Share-Based Compensation - Stock-Based Compensation, Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 2,152	$ 4,837	$ 4,899
Stock-based compensation awards classified as a liability settled in cash	(100)	$ 100	$ 600
Restricted Stock \| 2010 and 2017 Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 1,800
Period for recognition of unrecognized compensation cost	1 year 11 months 8 days

Share-Based Compensation - Stock Options, Narrative (Details) - shares	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)	0	0	0
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years
Vesting on January 1, 2019 \| Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting right percentage				33.33%
Vesting on the last day of each fiscal quarter following January 1, 2019 \| Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting right percentage				8.33%

Share-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Options (in thousands)
Outstanding beginning balance (in shares)	496,000	527,000	730,000
Granted (in shares)	0	0	0
Exercised (in shares)	(289,000)	(25,000)	(155,000)
Forfeited (in shares)	(20,000)	(1,000)	(19,000)
Expired or Canceled (in shares)	(9,000)	(5,000)	(29,000)
Outstanding ending balance (in shares)	178,000	496,000	527,000
Exercisable (in shares)	178,000
Weighted Average Exercise Price
Outstanding beginning balance (dollars per share)	$ 5.23	$ 5.12	$ 4.96
Granted (dollars per share)	0	0	0
Exercised (dollars per share)	4.77	3.00	4.52
Forfeited (dollars per share)	4.82	20.09	4.58
Expired or Canceled (dollars per share)	6.19	4.11	4.64
Outstanding ending balance (dollars per share)	5.96	$ 5.23	$ 5.12
Exercisable (dollars per share)	$ 5.96
Weighted Average Remaining Contractual Term (in years)
Outstanding	5 years 4 months 24 days
Exercisable	5 years 4 months 24 days
Aggregate Intrinsic Value (in thousands)
Exercised	$ 1,590	$ 283	$ 1,328
Outstanding	410
Exercisable	$ 410

Share-Based Compensation - Restricted Shares (Details) - $ / shares	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Restricted Shares
Shares
Nonvested beginning period (in shares)	40,000	90,000	109,000
Granted (in shares)	41,000	30,000	37,000
Vested (in shares)	(40,000)	(80,000)	(56,000)
Forfeited (in shares)	0	0	0
Nonvested ending period (in shares)	41,000	40,000	90,000
Weighted Average Grant Date Fair Value
Nonvested beginning period (dollars per share)	$ 12.74	$ 7.87	$ 5.43
Granted (dollars per share)	11.14	15.2	11.59
Vested (dollars per share)	12.74	8.19	5.55
Forfeited (dollars per share)	0	0	0
Nonvested ending period (dollars per share)	$ 11.14	$ 12.74	$ 7.87
Restricted Stock Units (RSUs)
Shares
Nonvested beginning period (in shares)	239,000	340,000	0
Granted (in shares)	202,000	122,000	347,000
Vested (in shares)	(135,000)	(221,000)	0
Forfeited (in shares)	(121,000)	(2,000)	(7,000)
Nonvested ending period (in shares)	185,000	239,000	340,000
Weighted Average Grant Date Fair Value
Nonvested beginning period (dollars per share)	$ 13.68	$ 13.81	$ 0
Granted (dollars per share)	12.77	13.64	13.81
Vested (dollars per share)	13.07	13.87	0
Forfeited (dollars per share)	14.60	12.92	13.51
Nonvested ending period (dollars per share)	$ 12.54	$ 13.68	$ 13.81
Performance Restricted Stock Units
Shares
Nonvested beginning period (in shares)	109,000	450,000	630,000
Granted (in shares)	49,000	357,000	348,000
Vested (in shares)	(55,000)	(658,000)	(479,000)
Forfeited (in shares)	(91,000)	(40,000)	(49,000)
Nonvested ending period (in shares)	12,000	109,000	450,000
Weighted Average Grant Date Fair Value
Nonvested beginning period (dollars per share)	$ 13.61	$ 7.71	$ 8.82
Granted (dollars per share)	14.50	6.96	12.98
Vested (dollars per share)	13.08	5.88	13.28
Forfeited (dollars per share)	14.39	15.02	4.99
Nonvested ending period (dollars per share)	$ 13.85	$ 13.61	$ 7.71

Share-Based Compensation - Restricted Stock, Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards	$ 500	$ 1,000	$ 700
Shares vested (in shares)	40,000	80,000	56,000
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards	$ 1,600	$ 3,300	$ 3,300
Shares vested (in shares)	135,000	221,000	0

Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details) - Performance Restricted Stock Units - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards	$ 0.6	$ 10.1	$ 6.3
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Distribution percentage of target number of Performance Stock Units			0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Distribution percentage of target number of Performance Stock Units			200.00%

Share-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Shares
Nonvested beginning period (in shares)	109	450	630
Granted (in shares)	49	357	348
Vested (in shares)	(55)	(658)	(479)
Forfeited (in shares)	(91)	(40)	(49)
Nonvested ending period (in shares)	12	109	450
Weighted Average Grant Date Fair Value
Nonvested beginning period (dollars per share)	$ 13.61	$ 7.71	$ 8.82
Granted (dollars per share)	14.50	6.96	12.98
Vested (dollars per share)	13.08	5.88	13.28
Forfeited (dollars per share)	14.39	15.02	4.99
Nonvested ending period (dollars per share)	$ 13.85	$ 13.61	$ 7.71

Share-Based Compensation - Cash-Settled Performance Units (Details) - Cash-Settled Performance Units - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Shares
Nonvested beginning period (in shares)	50	58
Granted (in shares)	0	42
Vested (in shares)	(42)	(32)
Forfeited (in shares)	(8)	(18)
Nonvested ending period (in shares)	0	50
Weighted Average Grant Date Fair Value
Granted (dollars per share)	$ 0	$ 11.27
Vested (dollars per share)	0	0
Forfeited (dollars per share)	$ 7.68	$ 9.07

Share-Based Compensation - Cash-Settled Performance Units, Narrative (Details) - Cash-Settled Performance Units - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards		$ 0.4	$ 0.4
Payments made to settle vested performance share units	$ 0.4	$ 0.3	$ 0.3

Share-Based Compensation - Cash-Settled Phantom Units (Details) - Cash-Settled Phantom Units - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Shares
Nonvested beginning period (in shares)	0	0	170,000
Granted (in shares)			0
Vested (in shares)			(170,000)
Forfeited (in shares)			0
Nonvested ending period (in shares)	0	0	0
Aggregate Intrinsic Value (in thousands)
Outstanding, beginning period		$ 0	$ 273
Granted			0
Vested			1,619
Forfeited			0
Outstanding, ending period			$ 0

Share-Based Compensation - Cash-Settled Phantom Units, Narrative (Details) - shares	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2018
Cash-Settled Phantom Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units outstanding (in shares)	0	0	0	170,000

Other Expense, Net (Details) - USD ($) $ in Thousands	12 Months Ended
Other Expense, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Other Income and Expenses [Abstract]
Foreign currency transaction gain (loss), net	$ 201	$ (434)	$ (121)
Loss on settlement of forward contract	(571)	(368)	(287)
Gain on disposal of fixed assets	7	3	0
Other (expense) income, net	(3)	114	147
Total other expense, net	$ (366)	$ (685)	$ (261)

Income Taxes - Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Income Before Income Taxes:
Domestic	$ 15,233	$ 12,817	$ 6,596
International	1,999	1,844	2,634
Income Before Income Taxes	17,232	14,661	9,230
Current Taxes:
Federal	2,146	1,297	222
State	510	332	176
Foreign	730	1,113	833
Total Current Income Tax Provision	3,386	2,742	1,231
Deferred Taxes:
Federal	897	316	502
State	197	71	109
Foreign	(142)	(17)	(41)
Total Deferred Income Tax Provision	952	370	570
Net Income Tax Provision	$ 4,338	$ 3,112	$ 1,801

Income Taxes - Effective Income Tax Rate (Details)	12 Months Ended
Income Taxes - Effective Income Tax Rate (Details)	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
The effective income tax rate differs from the U.S. Federal statutory income tax rate
Federal statutory income tax rate	21.00%	21.00%	21.00%
State income taxes, net of federal benefit	3.60%	3.80%	3.10%
Foreign tax rate difference	2.10%	1.40%	4.50%
Tax return to provision true-up	(0.70%)	0.00%	(1.10%)
Limit on future stock compensation due to 162(m)	1.70%	2.30%	2.60%
Foreign withholding tax	0.40%	3.30%	0.00%
Other differences	1.50%	1.90%	(0.10%)
Revalue of deferred for change in federal tax rate	0.10%	(0.10%)	(0.60%)
Permanent differences:
— stock based compensation	(2.30%)	(13.60%)	(7.70%)
— current year section 162(m) limitation	0.00%	1.60%	0.00%
— foreign derived intangible income deduction	(0.60%)	(0.50%)	(0.10%)
— tax credits	(1.40%)	(2.30%)	(3.70%)
— meals and entertainment	0.10%	0.40%	0.70%
— other permanent differences	0.90%	1.80%	1.70%
Change in valuation allowance	(1.20%)	0.20%	(0.80%)
Net income tax provision	25.20%	21.20%	19.50%

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020
Deferred tax assets:
Federal, state, and foreign net operating loss carryovers	$ 271	$ 501
Stock option compensation	444	824
Accrued vacation, allowance for returns, bonuses & other	2,104	2,067
Gross deferred tax asset	2,819	3,392
Deferred tax liabilities:
Patents and trademarks	(99)	(117)
Property & equipment	(1,250)	(801)
Other	(189)	(59)
Gross deferred tax liabilities	(1,538)	(977)
Less: valuation allowance	(73)	(251)
Deferred tax assets, net	$ 1,208	$ 2,164

Income Taxes - Unrecognized Tax Benefits Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, beginning of period	$ 480	$ 0
Gross increases - tax positions in prior period	0	0
Gross decreases - tax positions in prior period	(480)	0
Gross increases - tax positions in current period	0	480
Settlement	0	0
Lapse of statute of limitations	0	0
Currency adjustment	0	0
Unrecognized tax benefits, end of period	$ 0	$ 480

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2020
Operating Loss Carryforwards [Line Items]
Tax benefit from settlement of stock based awards	$ 8	$ 2,000
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	6,700
Foreign Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 100

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Leases - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Lessee, Lease, Description [Line Items]
Weighted average remaining lease term	8 years 11 months 4 days
Weighted average discount rate	3.28%
Operating lease expense	$ 3.6	$ 2.7
Operating leases rent expense			$ 2.7
Minimum
Lessee, Lease, Description [Line Items]
Lease term	2 years
Maximum
Lessee, Lease, Description [Line Items]
Lease term	11 years

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Leases [Abstract]
Operating cash outflows from operating leases	$ 2,536	$ 2,886
Right-of-use assets obtained in exchange for lease obligations	$ 15,725	$ 0

Leases - Maturity of Lease Liabilities (Details) $ in Thousands	Jun. 30, 2021 USD ($)
Leases [Abstract]
2022	$ 2,550
2023	3,167
2024	1,876
2025	1,606
2026	1,646
Thereafter	9,810
Total	20,655
Less: imputed interest	(2,472)
Present value of lease liabilities	$ 18,183

Commitments and Contingencies - Legal Accruals (Details)	Dec. 05, 2019 claim
Commitments and Contingencies Disclosure [Abstract]
Claims dismissed	3
Pending claims	4

Related Party Disclosures (Details)	12 Months Ended
Related Party Disclosures (Details)	Jun. 30, 2021 USD ($) member	Jun. 30, 2020 USD ($)
Related Party Transaction [Line Items]
Members of company board of directors serving on GEG board of directors \| member	2
GEG
Related Party Transaction [Line Items]
Related party purchase \| $	$ 0	$ 1,200,000

Interim Financial Results (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Summary of selected quarterly financial information
Revenue, net	$ 54,777	$ 51,570	$ 59,007	$ 54,827	$ 59,368	$ 56,077	$ 61,242	$ 56,228	$ 220,181	$ 232,915	$ 225,958
Gross profit	44,995	42,752	48,818	45,429	49,919	46,982	51,012	47,038	181,994	194,951	187,985
Net income	$ 4,907	$ 1,724	$ 3,812	$ 2,451	$ 3,824	$ 1,661	$ 4,303	$ 1,761	$ 12,894	$ 11,549	$ 7,429
Per common share:
Income per share, basic (dollars per share)	$ 0.36	$ 0.12	$ 0.27	$ 0.17	$ 0.27	$ 0.12	$ 0.31	$ 0.13	$ 0.92	$ 0.82	$ 0.53
Income per share, diluted (dollars per share)	$ 0.35	$ 0.12	$ 0.26	$ 0.17	$ 0.26	$ 0.11	$ 0.30	$ 0.12	$ 0.90	$ 0.79	$ 0.50

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.